Test | Results | Alternative diagnoses | Next steps | |
---|---|---|---|---|
Expected results for patient with PCOS | Results for a patient with an alternative diagnosis | |||
Prolactin | Normal | Markedly elevated | Pituitary tumour |
|
TSH | Normal | Elevated | Hypothyroidism |
|
Depressed | Hyperthyroidism |
| ||
FSH, LH and estradiol | Normal–high LH and normal FSH in the context of low follicular phase estradiol | High FSH and LH in the context of low follicular phase estradiol | POI |
|
Low FSH, LH and estradiol | Hypogonadotropic hypogonadism | |||
β-hCG | Negative | Positive | Pregnancy | |
17-OHP | Normal | Elevated | Non-classic adrenal hyperplasia |
|
Calculated free testosterone, total testosterone and free androgen index | Normal–mildly elevated | Markedly elevated total testosterone (> 5.2 nmol/L) (14) | Ovarian or adrenal tumour |
|
Androstenedione | Normal–mildly elevated | Markedly elevated | Non-classic adrenal hyperplasia or possible adrenal tumour |
|
Dehydroepiandrosterone sulfate | Normal–mildly elevated | Elevated (> 18.9 μmol/L) (14) | Adrenal tumour |
|
Transvaginal ultrasonography | PCOM (≥ 10 mL ovarian volume or ≥ 20 follicles in either ovary) | Ovarian tumour |
| |
Anti-müllerian hormone | Typically greater than 34 pmol/L (15) | Undetectable | POI (if age < 40 yr) |
|
Low | Age-related decline in ovarian reserve |
Note: CT = computed tomography, FSH = follicle-stimulating hormone, LH = luteinizing hormone, MRI = magnetic resonance imaging, PCOM = polycystic ovarian morphology, PCOS = polycystic ovarian syndrome, POI = premature ovarian insufficiency, TSH = thyroid-stimulating hormone, 17-OHP = 17-hydroxyprogesterone, β-hcg = β-human chorionic gonadotropin.